Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 


Upcoming Unit Investment Trust Deposits
Portfolio Name Ticker Initial Offer Date Cash CUSIP(s) Reinvest CUSIP(s) Term
International High Dividend Equity, 41 FQARHX 9/21/2020
30315P424
30315P440 (Fee)
30315P432
30315P457 (Fee)
2 Year
Cboe Vest Large Cap Deep Buffered, 7 FIFVWX 9/22/2020
30315N643
30315N650 (Fee)
2 Year
Dividend & Income Select Closed-End, 83 FNUSPX 9/23/2020
30315N346
30315N361 (Fee)
30315N353
30315N379 (Fee)
2 Year
Equity Income Opportunity, 14 FOXRYX 9/23/2020
30315N429
30315N445 (Fee)
30315N437
30315N452 (Fee)
15 Month
Homebuilders Recovery Select, 24 FLYLAX 9/23/2020
30315N387
30315N403 (Fee)
30315N395
30315N411 (Fee)
2 Year
MLP Closed-End, 31 FOEJSX 9/23/2020
30315N460
30315N486 (Fee)
30315N478
30315N494 (Fee)
2 Year
Senior Loan & Limited Duration Opportunities Closed-End, 71 FNLBMX 9/23/2020
30315N585
30315N601 (Fee)
30315N593
30315N619 (Fee)
15 Month
FT Income, 9 FMICDX 9/24/2020
30315N668
30315N684 (Fee)
30315N676
30315N692 (Fee)
15 Month
Key 3, 12 FNBKJX 9/25/2020
30315N700
30315N726 (Fee)
30315N718
30315N734 (Fee)
2 Year
New York Municipal Income Select Closed-End, 60 FLOTXX 9/25/2020
30315Q307
30315Q323 (Fee)
30315Q315
30315Q331 (Fee)
2 Year
REIT Growth & Income Select, 55 FPRAEX 9/25/2020
30315N221
30315N247 (Fee)
30315N239
30315N254 (Fee)
2 Year
Worldwide Economic Recovery, 8 FOOAVX 9/25/2020
30315N742
30315N767 (Fee)
30315N759
30315N775 (Fee)
2 Year
International Capital Strength, 48 ------- 9/28/2020
30315P101
30315P127 (Fee)
30315P119
30315P135 (Fee)
2 Year
Sabrient Dividend Opportunity, 11 ------- 9/28/2020
30315N502
30315N528 (Fee)
30315N510
30315N536 (Fee)
15 Month
Sabrient Dividend, 33 ------- 9/28/2020
30315N544
30315N569 (Fee)
30315N551
30315N577 (Fee)
2 Year
SMid Capital Strength, 48 ------- 9/28/2020
30315P143
30315P168 (Fee)
30315P150
30315P176 (Fee)
2 Year
Technology Select, 79 ------- 9/28/2020
30315P184
30315P200 (Fee)
30315P192
30315P218 (Fee)
2 Year
FT Equity Allocation ETF Model, 4th Qtr 2020 ------- 9/29/2020
30315L787
30315L803 (Fee)
30315L795
30315L811 (Fee)
15 Month
FT High Income Model, 4th Qtr 2020 ------- 9/29/2020
30315L829
30315L845 (Fee)
30315L837
30315L852 (Fee)
15 Month
FT Short Duration Fixed Income Model Portfolio, 4th Qtr '20 ------- 9/29/2020
30315P382
30315P408 (Fee)
30315P390
30315P416 (Fee)
15 Month
Pharmaceutical Select, 42 ------- 10/7/2020
30315P580
30315P606 (Fee)
30315P598
30315P614 (Fee)
2 Year
S&P International Dividend Aristocrats, 4th Qtr 2020 ------- 10/7/2020
30315P622
30315P648 (Fee)
30315P630
30315P655 (Fee)
15 Month
Diversified Equity Strategic Allocation, 4th Qtr 2020 ------- 10/9/2020
30315M744
30315M769 (Fee)
30315M751
30315M777 (Fee)
15 Month
Dow® Target 10, October 2020 ------- 10/12/2020
30315M702
30315M728 (Fee)
30315M710
30315M736 (Fee)
13 Month
Dow® Target 5, 4th Qtr 2020 ------- 10/12/2020
30315M181
30315M207 (Fee)
30315M199
30315M215 (Fee)
15 Month
Dow® Target Dividend, 4th Qtr 2020 ------- 10/12/2020
30315M223
30315M249 (Fee)
30315M231
30315M256 (Fee)
15 Month
Income Allocation Closed-End, 4th Qtr 2020 ------- 10/12/2020
30315M660
30315M686 (Fee)
30315M678
30315M694 (Fee)
15 Month
S&P Dividend Aristocrats Target 25, 4th Qtr 2020 ------- 10/12/2020
30315M264
30315M280 (Fee)
30315M272
30315M298 (Fee)
15 Month
S&P Target 24, 4th Qtr 2020 ------- 10/12/2020
30315M306
30315M322 (Fee)
30315M314
30315M330 (Fee)
15 Month
S&P Target SMid 60, 4th Qtr 2020 ------- 10/12/2020
30316B101
30316B127 (Fee)
30316B119
30316B135 (Fee)
15 Month
Target Diversified Dividend, 4th Qtr 2020 ------- 10/12/2020
30315M348
30315M363 (Fee)
30315M355
30315M371 (Fee)
15 Month
Target Diversified Global Allocation, 4th Qtr 2020 ------- 10/12/2020
30315M462
30315M488 (Fee)
30315M470
30315M496 (Fee)
15 Month
Target Dividend Blend, 4th Qtr 2020 ------- 10/12/2020
30315M587
30315M603 (Fee)
30315M595
30315M611 (Fee)
15 Month
Target Dividend Double Play, 4th Qtr 2020 ------- 10/12/2020
30315M504
30315M520 (Fee)
30315M512
30315M538 (Fee)
15 Month
Target Dividend Triple Play, 4th Qtr 2020 ------- 10/12/2020
30315M546
30315M561 (Fee)
30315M553
30315M579 (Fee)
15 Month
Target Double Play, 4th Qtr 2020 ------- 10/12/2020
30315M785
30315M801 (Fee)
30315M793
30315M819 (Fee)
15 Month
Target Focus Four, 4th Qtr 2020 ------- 10/12/2020
30316B143
30316B168 (Fee)
30316B150
30316B176 (Fee)
15 Month
Target Global Dividend Leaders, 4th Qtr 2020 ------- 10/12/2020
30315M389
30315M405 (Fee)
30315M397
30315M413 (Fee)
15 Month
Target Growth, 4th Qtr 2020 ------- 10/12/2020
30316B184
30316B200 (Fee)
30316B192
30316B218 (Fee)
15 Month
Target High Quality Dividend, 4th Qtr 2020 ------- 10/12/2020
30315M629
30315M645 (Fee)
30315M637
30315M652 (Fee)
15 Month
Target Triad, 4th Qtr 2020 ------- 10/12/2020
30316B226
30316B242 (Fee)
30316B234
30316B259 (Fee)
15 Month
Target VIP, 4th Qtr 2020 ------- 10/12/2020
30316B267
30316B283 (Fee)
30316B275
30316B291 (Fee)
15 Month
Value Line® Target 25, 4th Qtr 2020 ------- 10/12/2020
30315M421
30315M447 (Fee)
30315M439
30315M454 (Fee)
15 Month
Value Line® Target Safety 30, 4th Qtr 2020 ------- 10/12/2020
30315M140
30315M165 (Fee)
30315M157
30315M173 (Fee)
15 Month
40/60 Strategic Allocation, 4th Qtr 2020 ------- 10/13/2020
30315Q380
30315Q406 (Fee)
30315Q398
30315Q414 (Fee)
15 Month
60/40 Strategic Allocation, 4th Qtr 2020 ------- 10/13/2020
30315Q224
30315Q240 (Fee)
30315Q232
30315Q257 (Fee)
15 Month
75/25 Strategic Allocation, 4th Qtr 2020 ------- 10/13/2020
30315Q265
30315Q281 (Fee)
30315Q273
30315Q299 (Fee)
15 Month
Diversified Fixed Income ETF, 45 ------- 10/13/2020
30315L704
30315L720 (Fee)
30315L712
30315L738 (Fee)
15 Month
American Recovery, 3 ------- 10/14/2020
30315Q422
30315Q448 (Fee)
30315Q430
30315Q455 (Fee)
2 Year
Content Leaders Opportunity, 17 ------- 10/14/2020
30315N825
30315N841 (Fee)
30315N833
30315N858 (Fee)
15 Month
Content Leaders, 19 ------- 10/14/2020
30315P226
30315P242 (Fee)
30315P234
30315P259 (Fee)
15 Month
High-Yield Income Closed-End, 91 ------- 10/14/2020
30315Q182
30315Q208 (Fee)
30315Q190
30315Q216 (Fee)
2 Year
Market Strength Allocation Opportunity, 15 ------- 10/14/2020
30315P820
30315P846 (Fee)
30315P838
30315P853 (Fee)
15 Month
Cboe Vest Large Cap Buffered, 12 ------- 10/15/2020
30315U266
30315U274 (Fee)
15 Month
Municipal Advantage Closed-End and ETF, 62 ------- 10/15/2020
30315Q349
30315Q364 (Fee)
30315Q356
30315Q372 (Fee)
2 Year
High Dividend Equity, 46 ------- 10/16/2020
30315P705
30315P721 (Fee)
30315P713
30315P739 (Fee)
2 Year
Technology Dividend, 36 ------- 10/16/2020
30315P747
30315P762 (Fee)
30315P754
30315P770 (Fee)
2 Year
Sabrient Baker's Dozen, 4th Qtr 2020 ------- 10/20/2020
30315P267
30315P283 (Fee)
30315P275
30315P291 (Fee)
15 Month
Select DSIP, 4th Qtr 2020 ------- 10/20/2020
30315P309
30315P325 (Fee)
30315P317
30315P333 (Fee)
15 Month
American Agenda, 15 ------- 10/23/2020
30315P788
30315P804 (Fee)
30315P796
30315P812 (Fee)
2 Year
Dividend Edge, 16 ------- 10/28/2020
30315Q109
30315Q125 (Fee)
30315Q117
30315Q133 (Fee)
15 Month
Dow® Target 10, November 2020 ------- 11/10/2020
30315P663
30315P689 (Fee)
30315P671
30315P697 (Fee)
13 Month


 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2020 All rights reserved.